Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – C-o-group doai
Reexamination Certificate
2007-12-25
2007-12-25
Keys, Rosalynd (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
C-o-group doai
C514S737000, C568S775000
Reexamination Certificate
active
10095810
ABSTRACT:
The present invention relates to the synthesis of fluorinated forms of alkyl phenol compounds and their subsequent use as pharmaceutical agents. More specifically, alkyl phenol compounds are fluorinated to increase compound volatility such that the compound may be administered to a mammal, such as a human being, by inhalation. The invention also provides an inhaler (or vaporizer), that can be used for administration of the volatile derivatives of fluorine-substituted alkyl phenol compound. Further, different derivatives of fluorine-substituted alkyl phenol compound can be also administered by other routes as described in this document.
REFERENCES:
patent: 3346668 (1967-10-01), Dalton
patent: 3899517 (1975-08-01), Flectcher
patent: 3979463 (1976-09-01), Endres
patent: 4044153 (1977-08-01), Schultz
patent: 4067996 (1978-01-01), Najer
patent: 4731450 (1988-03-01), Wakselman
patent: 4982006 (1991-01-01), Hudec
patent: 5308874 (1994-05-01), Sanchez et al.
patent: 5461080 (1995-10-01), Sanchez et al.
patent: 5496537 (1996-03-01), Henry
patent: 6254853 (2001-07-01), Hendler et al.
patent: 2001/0004664 (2001-06-01), Asami et al.
patent: 04-285672 (1992-10-01), None
patent: 4-285672 (1992-10-01), None
Krusz, et al.; “Intravenous Propofol: Unique Effectiveness in Treating Intractable Migraine”;Headache; (2000), 40: 224-230.
Aarts, et al.; “The widely used anesthetic agent propofol can replace α-tocopherol as an antioxidant”;FEBS Let.; (1995), 357(1): 83-85.
Borgeat, et al.; “Propofol and Cholestatic Pruritus”;Amer. Journ. of Gastroent.; (1992), 87(5): 672-674.
Sagara, et al.; “Propofol Hemisuccinate Protects Neuronal Cells from Oxidative Injury”;J. Neurochem.; (1999), 73(6): 2524-30.
Jevtovic-Todorovic, et al.; “Propofol and sodium thiopental protect against MK-801-induced neuronal necrosis in the posterior cingulate/retrosplenial cortex”;Brain Res.; (2001), 913(2): 185-9.
Kelly, et al.; “Propofol in the treatment of moderate and severe head injury: a randomized, prospective double-blinded pilot trial”;Journ. of Neurosurg., (1999), 90: 1042-1052.
Briggs, et al.; “An adverse reaction to the administration of disoprofol (Diprivan)”;Anethesis; (1982), 37: 1099-1101.
McHugh, et al.; “Propofol emulsion and bacterial contamination”;Can. J. Anaesth.; (1995), 42(9): 801-804.
International Search Report based on PCT/US03/07146 dated Jun. 30, 2003.
Baker Max T.
Naguib Mohamed
Edwards Angell Palmer & & Dodge LLP
Keys Rosalynd
Russett Mark D.
University of Iowa Research Foundation
Williams Kathleen M.
LandOfFree
Fluorine-substituted alkyl phenol compounds and their uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fluorine-substituted alkyl phenol compounds and their uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fluorine-substituted alkyl phenol compounds and their uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3896225